Chemicals · Founded 2013 · www.vitalgroup.co.in · NSE · ISIN INE0L4K01016
No Notes Added Yet
Business
Vital Chemtech Ltd. is an Indian chemical manufacturer specializing in the production of high-performance specialty chemicals, primarily caterers for the Oil & Gas exploration and production (E&P) industry. The company's core business involves manufacturing products such as Oilfield Chemicals (e.g., drilling fluid additives, cementing additives, stimulation chemicals) and various specialty polymers. They also produce products for water treatment, industrial cleaning, and other industrial applications. The company makes money by manufacturing these specialized chemical formulations and selling them to industrial clients, often based on specific application requirements and performance demands.
Revenue Mix
While specific revenue percentages for each product category are not always readily disclosed, Vital Chemtech's primary business segments can be broadly categorized as:
Oilfield Chemicals: This segment focuses on chemicals critical for various stages of oil and gas exploration, drilling, production, and well stimulation. This is a significant revenue contributor.
Specialty Polymers & Performance Chemicals: This includes a range of polymers and performance chemicals used in various industrial applications beyond oil & gas, potentially including water treatment, industrial cleaning, and other process industries.
Industry
Vital Chemtech operates within the broader Indian chemicals sector, specifically in the specialty chemicals segment, which is generally less commoditized and more technology-driven. The Indian chemicals industry is diverse, with both large integrated players and numerous smaller, specialized manufacturers. Vital Chemtech positions itself as a niche player, focusing on high-performance chemicals for specific, demanding applications like the Oil & Gas E&P sector. This requires specialized R&D capabilities, technical expertise, and adherence to stringent quality standards. Compared to large diversified chemical giants, Vital Chemtech is a smaller, more focused entity, competing on product quality, customization, and technical support rather than scale alone.
MOAT
Vital Chemtech's potential competitive advantages include:
Specialized Product Portfolio & R&D: Their focus on high-performance chemicals for demanding applications (like Oil & Gas) implies a degree of technical know-how, specialized formulations, and ongoing R&D that can be difficult for general chemical manufacturers to replicate quickly.
Customer Integration & Switching Costs: For critical applications, customers often develop strong relationships with suppliers of proven chemical solutions due to the high costs associated with product failure or switching to unproven alternatives. This can create moderate switching costs.
Quality and Certifications: Adherence to industry-specific quality standards and certifications can act as an entry barrier and build customer trust.
Growth Drivers
Domestic Oil & Gas E&P Sector Growth: Increased activity and investments in India's upstream oil and gas sector will directly drive demand for Vital Chemtech's oilfield chemicals.
Import Substitution: Government initiatives and industry focus on 'Make in India' could lead to greater domestic sourcing of specialty chemicals, benefiting local manufacturers like Vital Chemtech.
Diversification & New Product Development: Expanding its product portfolio into new applications or developing advanced formulations for existing segments can open new revenue streams.
Capacity Expansion: Investing in increased manufacturing capacity to meet growing demand.
Exports: Tapping into international markets for its specialized chemical offerings.
Risks
Raw Material Price Volatility: Fluctuations in the prices of key raw materials can impact profit margins.
Dependence on Oil & Gas Sector: A significant slowdown or reduction in investment in the oil and gas E&P sector can severely impact demand for its core products.
Environmental & Regulatory Risks: Stricter environmental regulations or changes in chemical safety norms could lead to increased compliance costs or operational restrictions.
Intense Competition: The specialty chemical sector, while niche, still faces competition from both domestic and international players.
Technological Obsolescence: Rapid advancements in chemical technology or customer requirements could necessitate continuous R&D investment to remain competitive.
Economic Downturns: General economic slowdowns can reduce industrial demand across various sectors, impacting sales.
Management & Ownership
Vital Chemtech Ltd. is promoted by individuals with significant experience in the chemical industry. The company's management team is responsible for driving its strategic direction, R&D initiatives, and operational efficiency. As an Indian-listed entity, a substantial portion of the ownership typically resides with the promoter group, indicating their vested interest in the company's long-term success. The remaining shares are held by public shareholders, including institutional and retail investors.
Outlook
Vital Chemtech operates in the specialty chemicals segment, which generally commands better margins and offers growth potential compared to commodity chemicals, particularly with its focus on the Oil & Gas E&P sector. The company's specialized product portfolio and technical expertise are positives, offering some differentiation. Growth drivers include increasing domestic energy demand, potential for import substitution, and ongoing R&D efforts. However, the company faces risks from raw material price volatility and a significant reliance on the cyclical oil and gas industry. Environmental compliance and competitive pressures are ongoing challenges. The outlook remains balanced, contingent on the stability and growth of its key end-user industries, effective management of input costs, and successful expansion into new applications or geographies.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2025 | Mar 2026 |
|---|---|---|
| Net Sales | 35 | 35 |
| Other Income | 1 | 0 |
| Total Income | 36 | 35 |
| Total Expenditure | 32 | 31 |
| Operating Profit | 3 | 4 |
| Interest | 0 | 1 |
| Depreciation | 1 | 2 |
| Exceptional Income / Expenses | 0 | 0 |
| Profit Before Tax | 2 | 1 |
| Provision for Tax | 1 | 0 |
| Profit After Tax | 1 | 1 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 1 | 1 |
| Adjusted Earnings Per Share | 0.5 | 0.4 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 58 | 117 | 98 | 134 | 70 |
| Other Income | 0 | 0 | 3 | 2 | 1 |
| Total Income | 58 | 117 | 102 | 136 | 71 |
| Total Expenditure | 46 | 102 | 98 | 123 | 63 |
| Operating Profit | 12 | 15 | 4 | 13 | 7 |
| Interest | 0 | 1 | 1 | 2 | 1 |
| Depreciation | 1 | 2 | 3 | 5 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 11 | -0 | 6 | 3 |
| Provision for Tax | 3 | 3 | 1 | 2 | 1 |
| Profit After Tax | 8 | 8 | -1 | 4 | 2 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 8 | 8 | -1 | 4 | 2 |
| Adjusted Earnings Per Share | 4.7 | 3.4 | -0.5 | 1.7 | 0.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 37% | 32% | 0% | 0% |
| Operating Profit CAGR | 225% | 3% | 0% | 0% |
| PAT CAGR | 0% | -21% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -22% | -21% | NA% | NA% |
| ROE Average | 5% | 6% | 18% | 18% |
| ROCE Average | 7% | 7% | 11% | 11% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 15 | 90 | 84 | 92 |
| Minority's Interest | 0 | 0 | 0 | 1 |
| Borrowings | 21 | 22 | 16 | 40 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 |
| Total Current Liabilities | 45 | 25 | 37 | 48 |
| Total Liabilities | 81 | 138 | 137 | 182 |
| Fixed Assets | 17 | 21 | 43 | 68 |
| Other Non-Current Assets | 3 | 24 | 37 | 38 |
| Total Current Assets | 61 | 93 | 58 | 75 |
| Total Assets | 81 | 138 | 137 | 182 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 6 | 31 | 0 |
| Cash Flow from Operating Activities | -13 | -8 | 14 | 6 |
| Cash Flow from Investing Activities | 1 | -26 | -35 | -30 |
| Cash Flow from Financing Activities | 18 | 58 | -9 | 25 |
| Net Cash Inflow / Outflow | 6 | 24 | -30 | 0 |
| Closing Cash & Cash Equivalent | 6 | 31 | 0 | 1 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.7 | 3.36 | -0.54 | 1.69 |
| CEPS(Rs) | 5.12 | 4.33 | 0.56 | 3.77 |
| DPS(Rs) | 0 | 0.5 | 0.5 | 0 |
| Book NAV/Share(Rs) | 8.7 | 37.41 | 35.21 | 38.47 |
| Core EBITDA Margin(%) | 20 | 12.66 | 0.2 | 8.43 |
| EBIT Margin(%) | 19.24 | 10.8 | 0.91 | 6.26 |
| Pre Tax Margin(%) | 18.39 | 9.84 | -0.36 | 4.64 |
| PAT Margin (%) | 13.71 | 6.9 | -1.33 | 3.03 |
| Cash Profit Margin (%) | 14.92 | 8.88 | 1.35 | 6.74 |
| ROA(%) | 9.72 | 7.35 | -0.95 | 2.54 |
| ROE(%) | 54.03 | 15.45 | -1.5 | 4.6 |
| ROCE(%) | 21.75 | 14.89 | 0.78 | 6.7 |
| Receivable days | 264.37 | 125.02 | 143.97 | 117.58 |
| Inventory Days | 57.36 | 35.21 | 48.49 | 35.82 |
| Payable days | 264.94 | 90.83 | 92.16 | 99.82 |
| PER(x) | 0 | 22.86 | 0 | 29.62 |
| Price/Book(x) | 0 | 2.05 | 2.02 | 1.3 |
| Dividend Yield(%) | 0 | 0.65 | 0.7 | 0 |
| EV/Net Sales(x) | 0.64 | 1.56 | 1.99 | 1.25 |
| EV/Core EBITDA(x) | 3.13 | 12.22 | 55.38 | 12.54 |
| Net Sales Growth(%) | 0 | 102.63 | -15.82 | 36.26 |
| EBIT Growth(%) | 0 | 13.77 | -92.9 | 837.03 |
| PAT Growth(%) | 0 | 1.94 | -116.17 | 411.44 |
| EPS Growth(%) | 0 | -28.49 | -116.17 | 411.46 |
| Debt/Equity(x) | 2.49 | 0.32 | 0.31 | 0.52 |
| Current Ratio(x) | 1.34 | 3.66 | 1.58 | 1.56 |
| Quick Ratio(x) | 1.14 | 3.13 | 1.24 | 1.28 |
| Interest Cover(x) | 22.89 | 11.22 | 0.72 | 3.86 |
| Total Debt/Mcap(x) | 0 | 0.16 | 0.15 | 0.4 |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 |
| FII | 3.62 | 0.78 | 0.56 | 0.16 | 1.78 | 1.78 | 1.62 |
| DII | 1.48 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Public | 21.47 | 25.16 | 26.01 | 26.41 | 24.79 | 24.79 | 24.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
| FII | 0.09 | 0.02 | 0.01 | 0 | 0.04 | 0.04 | 0.04 |
| DII | 0.04 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.51 | 0.6 | 0.62 | 0.63 | 0.59 | 0.59 | 0.6 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +37% | +32% | — | — |
| Operating Profit CAGR | +225% | +3% | — | — |
| PAT CAGR | — | -21% | — | — |
| Share Price CAGR | -22% | -21% | — | — |
| ROE Average | +5% | +6% | +18% | +18% |
| ROCE Average | +7% | +7% | +11% | +11% |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 | 73.43 |
| FII | 3.62 | 0.78 | 0.56 | 0.16 | 1.78 | 1.78 | 1.62 |
| DII | 1.48 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.57 | 26.57 | 26.57 | 26.57 | 26.57 | 26.57 | 26.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 | 1.76 |
| FII | 0.09 | 0.02 | 0.01 | 0 | 0.04 | 0.04 | 0.04 |
| DII | 0.04 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.